Analyst Price Targets — QURE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 20, 2026 10:22 am | — | Goldman Sachs | $10.00 | $17.58 | TheFly | uniQure price target raised to $10 from $9 at Goldman Sachs |
| March 9, 2026 5:04 pm | Daniil Gataulin | Chardan Capital | $31.00 | $17.99 | StreetInsider | uniQure BV (QURE) PT Raised to $31 at Chardan |
| March 9, 2026 11:11 am | Yanan Zhu | Wells Fargo | $60.00 | $17.69 | StreetInsider | Wells Fargo Upgrades uniQure BV (QURE) to Overweight |
| March 9, 2026 10:26 am | Luca Issi | RBC Capital | $35.00 | $17.99 | TheFly | uniQure upgraded to Outperform from Sector Perform at RBC Capital |
| March 2, 2026 9:07 pm | Joseph Schwartz | Leerink Partners | $35.00 | $10.50 | StreetInsider | uniQure BV (QURE) PT Lowered to $35 at Leerink Partners |
| March 2, 2026 4:33 pm | Luca Issi | RBC Capital | $11.00 | $10.25 | StreetInsider | RBC Capital Downgrades uniQure BV (QURE) to Sector Perform, Lowers PT to $11 |
| March 2, 2026 4:23 pm | Paul Matteis | Stifel Nicolaus | $14.00 | $10.30 | StreetInsider | uniQure BV (QURE) PT Lowered to $14 at Stifel on FDA uncertainty |
| January 27, 2026 9:31 pm | — | Barclays | $31.00 | $24.37 | TheFly | uniQure initiated with an Equal Weight at Barclays |
| December 11, 2025 12:24 pm | — | Stifel Nicolaus | $40.00 | $20.12 | TheFly | uniQure price target lowered to $40 from $50 at Stifel |
| December 8, 2025 9:32 pm | Uy Ear | Mizuho Securities | $33.00 | $21.77 | TheFly | uniQure price target lowered to $33 from $60 at Mizuho |
Latest News for QURE
NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) of a class action securities lawsuit.
New York, New York--(Newsfile Corp. - April 13, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against uniQure N.V. (NASDAQ: QURE) and certain of its officers.
NEW YORK--(BUSINESS WIRE)---- $QURE #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi is a leading national…
LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LOS ANGELES, April 12, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against uniQure N.V. ("uniQure" or "the Company") (NASDAQ: QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for QURE.
U.S. House Trading
No House trades found for QURE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.